<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ENUIFTXN</identifier><date>2013</date><creator>Škrgat-Kristan, Sabina</creator><relation>documents/doc/E/URN_NBN_SI_doc-ENUIFTXN_001.htm</relation><relation>documents/doc/E/URN_NBN_SI_doc-ENUIFTXN_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-ENUIFTXN_001.txt</relation><format format_type="extent">142-149</format><format format_type="issue">3</format><format format_type="volume">82</format><format format_type="type">article</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">267980800</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ENUIFTXN</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">alergija</subject><subject language_type_id="eng">asthma</subject><subject language_type_id="slv">astma</subject><subject language_type_id="slv">omalizumab</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>The role of omalizumab in the treatment of adults with severe allergic asthma</title><title>Vloga omalizumaba pri zdravljenju odraslih bolnikov z alergijsko astmo</title></Record>